Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kost Forer Gabbay & Kasierer is the Israeli member firm of EY (Ernst & Young), serving as the largest professional services and accounting firm in Israel. While not a biotechnology or pharmaceutical developer itself, the firm is a critical player in the life sciences ecosystem, providing audit, tax, and strategic consulting services to a vast majority of Israeli healthcare and biotech companies. The firm specializes in assisting life science startups with international tax structuring, mergers and acquisitions, and initial public offerings on global exchanges like NASDAQ. Headquartered in Tel Aviv, it employs thousands of professionals who support the financial and operational growth of the Israeli high-tech and medical sectors. Their Life Sciences practice is recognized for its deep expertise in navigating the regulatory and financial complexities unique to drug development and medical device commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kost Forer Gabbay & Kasierer.